Anti Inflammation Kapseln
- ✓ 650 mg Bromelain pro Tagesportion
- ✓ 264 mg Kurkuma-Extrakt mit 251 mg Curcuminoiden
- ✓ 200 mg Berberis-Aristata-Extrakt mit 100 mg Berberin
- ⚠
Normaler Preis
€22,90
Sonderpreis
€20,38
-11%
Anti Inflammation von Gods Rage: 650 mg Bromelain, 264 mg Kurkuma-Extrakt und 200 mg Berberis-Aristata-Extrakt pro Tagesportion aus zwei Kapseln, ergänzt um Schwarzpfefferextrakt. Alle vier Pflanzenextrakte sind standardisiert, die Gehalte stehen offen in der Tabelle.
- 650 mg Bromelain je Tagesportion
- 264 mg Kurkumawurzelstockextrakt, davon 251 mg Curcuminoide
- 200 mg Berberis-Aristata-Extrakt, davon 100 mg Berberin
- 5 mg Schwarzpfefferextrakt, davon 4,75 mg Piperin
- 60 Kapseln entsprechen 30 Tagesportionen zu zwei Kapseln
- Kapselform, einmal täglich, ohne Anrühren
| Zusammensetzung | pro 2 Kapseln | % (NRV*) |
|---|---|---|
| Bromelain | 650 mg | ** |
| Kurkumawurzelstockextrakt | 264 mg | ** |
| davon Curcuminoide | 251 mg | ** |
| Berberis Aristata Extrakt | 200 mg | ** |
| davon Berberin | 100 mg | ** |
| Schwarzpfefferextrakt | 5,0 mg | ** |
| davon Piperin | 4,75 mg | ** |
Bromelain, Kurkumawurzelstockextrakt 50:1 (Curcuma longa, enthält 95 % Curcuminoide), Überzugsmittel: Hydroxypropylmethylcellulose (pflanzliche Kapselhülle), Berberis Aristata Extrakt 50:1 (Rinde), Schwarzpfefferextrakt (enthält 95 % Piperin).
Nimm einmal am Tag zwei (2) Kapseln unzerkaut
Hersteller / Distributor
Gods Rage Europe, London / United Kingdom
Nero Labs BV, Postbus 278, 5900AG Venlo, The Netherlands
- Walsh NP, Gleeson M, Shephard RJ, et al. Position statement. Part one: Immune function and exercise. Exerc Immunol Rev. 2011;17:6-63.
- Paulsen G, Mikkelsen UR, Raastad T, et al. Leucocytes, cytokines and satellite cells: what role do they play in muscle damage and regeneration following eccentric exercise? Exerc Immunol Rev. 2012;18:42-97.
- Febbraio MA, Pedersen BK. Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exerc Sport Sci Rev. 2005;33(3):114-119.
- Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol. 2005;288(2):R345-R353.
- Hittel DS, Berggren JR, Shearer J, Boyle K, Houmard JA. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes. 2009;58(1):30-38.
- Herder C, Schneitler S, Rathmann W, et al. Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab. 2007;92(12):4569-4574.
- Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327-334.
- Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003;107(3):391-397.
- Ford ES, Giles WH, Mokdad AH, Myers GL. Distribution and correlates of C-reactive protein concentrations among adult US women. Clin Chem. 2004;50(3):574-581.
- Engelhart MJ, Geerlings MI, Meijer J, et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Arch Neurol. 2004;61(5):668-672.
- Lai SW, Chen JH, Lin HY, Liu CS, Li TC, Tsai CF. Increased risk of dementia in patients with osteoporosis: a population-based retrospective cohort analysis. Age (Dordr). 2014;36(1):363-370.
- Brien S, Lewith GT, et al. Bromelain as an adjunctive treatment for osteoarthritis of the knee: a randomized controlled pilot study. QJM. 2006;99(12):841-850. doi: 10.1093/qjmed/hcl119
- Hale LP, Greer PK, Trinh CT, et al. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease. Clin Immunol. 2005;116(2):135-142. doi: 10.1016/j.clim.2005.03.003
- Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001;58(9):1234-1245. doi: 10.1007/PL00000936
- Miller PC, Bailey SP, Barnes ME, et al. The effects of protease supplementation on skeletal muscle function and DOMS following downhill running. J Sports Sci. 2004;22(4):365-372. doi: 10.1080/02640410310001655881
- Secor ER Jr, Singh A, et al. Bromelain treatment reduces CD25 expression on activated CD4+ T cells in vitro. Int Immunopharmacol. 2009;9(3):340-346. doi: 10.1016/j.intimp.2008.11.007
- Kheirouri S, Alizadeh M. Berberine natural alkaloid improves diabetic retinopathy through modulation of oxidative stress, inflammation and gene expression. Biomed Pharmacother. 2019;109:547-557. doi: 10.1016/j.biopha.2018.10.012
- Zhou Y, Ren Y, Zhang X, et al. Berberine hydrochloride attenuates lipopolysaccharide-induced endometritis in mice via suppression of the TLR4/NF-κB signaling pathway. Drug Des Devel Ther. 2018;12:775-783. doi: 10.2147/DDDT.S158337
- Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev. 2009;14(2):141-153. PMID: 19594223.
- Daily JW, Yang M, et al. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. J Med Food. 2016;19(8):717-729. doi: 10.1089/jmf.2016.3705
- Kuptniratsaikul V, Dajpratham P, et al. Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging. 2014;9:451-458. doi: 10.2147/CIA.S58535
- Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med. 2003 Feb;9(1):161-8. doi: 10.1089/107555303321223035. PMID: 12676044.
- Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009 Jan;41(1):40-59. doi: 10.1016/j.biocel.2008.06.010. Epub 2008 Jun 25. PMID: 18662800.
- Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, Sartor RB. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999 May 1;163(9):3474-83. PMID: 10553082.
Artikelnr.: 7378


